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t is estimated that there are some 
252,000–312,000 Americans living 
with HIV yet unaware that they 
carry this deadly virus [1]. Once they 
develop symptoms of HIV disease, most 
will be diagnosed. But by then, their 
immune systems will have experienced 
permanent damage, and thousands 
will have inadvertently infected their 
partners. One analysis reckons that 
annual HIV transmission rates in the 
United States are some 3.5 times higher 
among people with undiagnosed HIV 
infection compared to those who are 
diagnosed [2], due to the fact that 
knowledge of positive HIV serostatus is 
associated with substantial decreases in 
high-risk sexual behaviors among those 
so diagnosed [3].
Although HIV remains a very serious 
medical concern, with the advent of 
improved antiretroviral treatments it 
is no longer the hopeless condition it 
was in the early 1980s. Yet late diagnosis 
of HIV infection remains a problem 
in the US three decades after the 
syndrome was ﬁ  rst described, despite 
the substantial medical and public 
health beneﬁ  ts of early HIV diagnosis. 
In the US, about 40% of persons who 
were diagnosed with AIDS in 2005 
had their ﬁ  rst positive HIV test less 
than 12 months before their AIDS 
diagnosis [4]—meaning that they were 
infected with HIV for years prior to 
their initial diagnosis. Nor can late HIV 
diagnosis be simplistically ascribed to 
lack of access to health care. A variety 
of studies have shown that failure 
to diagnose HIV in a timely manner 
occurs even among persons who have 
regular access to health care [5–7].
“Opt-Out” HIV Testing in Health-
Care Settings
Arguably, addressing the persistent 
problem of late HIV diagnosis was 
the major driver in the recent push 
by the Centers for Disease Control 
and Prevention (CDC) for routine, 
opt-out testing in health-care settings, 
i.e., informing patients of the intent 
to perform HIV testing and inferring 
consent unless the patient declines 
[8]. Citing the time constraints of risk-
assessment and counseling, CDC’s 2006 
guidelines also note that “prevention 
counseling should not be required with 
HIV diagnostic testing or as part of HIV 
screening in health care settings” [8].
In a new study published in PLoS 
Medicine, David Holtgrave estimates 
the overall costs of CDC’s routine 
HIV testing recommendations using 
standard methods of scenario and cost-
effectiveness analysis [9]. His ﬁ  ndings 
are provocative: in his scenarios, 
targeted HIV counseling and testing 
performed better than opt-out testing 
in terms of expense, number of newly 
identiﬁ  ed patients, and prevention of 
HIV transmission [9].
Another salient feature of Holtgrave’s 
analysis is his focus on the role of 
counseling in the context of HIV testing. 
He reminds readers that a randomized 
controlled trial sponsored by CDC 
in the late 1990s demonstrated that 
interactive client-centered counseling 
could reduce risk behaviors and the 
incidence of new sexually transmitted 
infections [10]. Although earlier CDC 
guidelines had already taken steps to 
streamline requirements for pretest 
counseling—acknowledging providers’ 
need for ﬂ  exibility based on client 
base, HIV prevalence in the health-
care setting, and available resources 
[11]—the 2006 guidelines go even 
further. Prevention counseling is no 
longer identiﬁ  ed as a requirement for 
HIV screening in health-care settings. 
One of Holtgrave’s scenarios addresses 
this change, positing an increase in 
HIV incidence resulting from certain 
high-risk persons who, in the absence of 
counseling, might interpret negative test 
results as endorsing the “safety” of their 
behaviors.
Implications of the Study 
Perspectives on how best to encourage 
early diagnosis of HIV infection will 
continue to evolve as additional 
program implementation data and 
improved input parameters become 
available to further reﬁ  ne cost-
effectiveness analyses. But it would 
be a serious mistake to narrow this 
multifaceted discussion to an artiﬁ  cial 
dichotomy of opt-out routine testing 
versus targeted HIV testing. 
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Linked Research Article
This Perspective discusses the following 
new study published in PLoS Medicine:
Holtgrave DR (2007) Costs and 
consequences of the US Centers for 
Disease Control and Prevention’s 
recommendations for opt-out HIV 
testing. PLoS Med 4(6): e194. doi:10.1371/
journal.pmed.0040194
Scenario and cost-effectiveness 
analyses found that for the same 
programmatic cost, targeted counseling 
and testing would diagnose more people 
living with HIV and prevent more HIV 
infections than opt-out testing.PLoS Medicine  |  www.plosmedicine.org 0976
A broader, and perhaps more 
relevant, question worthy of further 
study is “How can we conﬁ  gure 
and sustain health-care systems 
that are capable of promoting and 
incentivizing necessary prevention 
services such as early HIV diagnosis?” 
[12]. These systems should be able 
to address the needs of individual 
patients, such as those patients who 
might require more time to accept 
HIV testing, even in an opt-out 
scenario, or those patients who receive 
a negative HIV test result, but require 
active intervention to facilitate changes 
in ongoing high-risk behaviors. In 
our current systems of care, limited 
provider time and competing 
demands are well-recognized obstacles 
to the optimal delivery of a host of 
clinical preventive services—not just 
HIV counseling and testing [13]. And 
although prioritization of clinical 
preventive services at a population 
level is a practical strategy to allocate 
scarce prevention resources [13], it 
may not serve the prevention needs of 
individuals or subgroups.
Future research on the timely 
diagnosis of HIV infection must 
include operational studies and systems 
analyses that explicitly evaluate the 
impact of changes in the design of 
health-care delivery systems (including 
referral systems) on the receipt of life-
saving services like HIV testing and, 
when needed, ongoing risk reduction 
counseling [14].  
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